Defining the Intramembrane Binding Mechanism of Sarcolipin to Calcium ATPase Using Solution NMR Spectroscopy

Journal of Molecular Biology

Volumn 358, Issue 2, 2006, Pages 420-429

  Buffy, Jarrod J ^a,b   Buck Koehntop, Bethany A ^a   Porcelli, Fernando ^a,c   Traaseth, Nathaniel J ^a   Thomas, David D ^b   Veglia, Gianluigi ^a,b  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Ca ATPase; phospholamban; sarcolipin; SERCA; solution NMR

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); DODECYLPHOSPHORYLCHOLINE; MEMBRANE PROTEIN; SARCOLIPIN; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; MEMBRANE BINDING; MICELLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE;

EID: 33646110094     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.02.005     Document Type: Article

References (46)

1. Wawrzynow A., Theibert J.L., Murphy C., Jona I., Martonosi A., and Collins J.H. Sarcolipin, the "proteolipid" of skeletal muscle sarcoplasmic reticulum, is a unique, amphipathic, 31-residue peptide. Arch. Biochem. Biophys. 298 (1992) 620-623
2. Odermatt A., Taschner P.E.M., Schere S.W., Beatty B., Khanna V.K., Cornblath D.R., et al. Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics 45 (1997) 541-553
3. 2+-ATPase. J. Biol. Chem. 273 (1998) 12360-12369
4. Simmerman H.K., Collins J.H., Theibert J.L., Wegener A.D., and Jones L.R. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261 (1986) 13333-13341
5. Vangheluwe P., Schuermans M., Zador E., Raeymaekers L., and Wuytack F. Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. Biochem. J. 389 (2005) 151-159
6. Gayan-Ramirez G., Vanzeir L., Wuytack F., and Decramer M. Corticosteroids decrease mRNA levels of SERCA pumps, whereas they increase sarcolipin mRNA in the rat diaphragm. J. Physiol. 524 (2000) 387-397
7. 2+ uptake and impairs contractile function. J. Biol. Chem. 277 (2002) 44740-44746
8. Minamisawa S., Wang Y., Chen J., Ishikawa Y., Chien K.R., and Matsuoka R. Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J. Biol. Chem. 278 (2003) 9570-9575
9. Babu G.J., Zheng Z., Natarajan P., Wheeler D., Janssen P.M., and Periasamy M. Overexpression of sarcolipin decreases myocyte contractility and calcium transient. Cardiovasc. Res. 65 (2005) 177-186
10. 2+-ATPases. Proc. Natl Acad. Sci. USA 101 (2004) 16807-16812
11. Lee A.G. A calcium pump made visible. Curr. Opin. Struct. Biol. 12 (2002) 547-554
12. 2+-ATPase of skeletal-muscle sarcoplasmic reticulum. Biochem. J. 361 (2002) 277-286
13. 2+-ATPases (SERCAs). J. Biol. Chem. 227 (2002) 26725-26728
14. 2+-ATPase (SARCA) by binding to transmembrane helices alone or in association with phospholamban. Proc. Natl Acad. Sci. USA 100 (2003) 5040-5045
15. 2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc. Natl Acad. Sci. USA 101 (2004) 9199-9204
16. MacLennan D.H., Asahi M., and Tupling A.R. The regulation of SERCA-type pumps by phospholamban and sarcolipin. Ann. N.Y. Acad. Sci. 986 (2003) 472-480
17. Zamoon J., Mascioni A., Thomas D.D., and Veglia G. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys. J. 85 (2003) 2589-2598
18. Buck B., Zamoon J., Kirby T.L., DeSilva T.M., Karim C., Thomas D., and Veglia G. Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies. Protein Express. Purif. 30 (2003) 253-261
19. Mascioni A., Karim C., Thomas D.D., and Veglia G. Structure and orientation of sarcolipin in lipid environments. Biochemistry 41 (2001) 475-482
20. Zamoon J., Nitu F., Karim C., Thomas D.D., and Veglia G. Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phopholamban in calcium pump regulation. Proc. Natl Acad. Sci. USA 102 (2005) 4747-4752
21. Wishart D.S., Sykes B.D., and Richards F.M. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 222 (1991) 311-333
22. Wishart D.S., and Sykes B.D. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31 (1992) 1647-1651
23. Metcalfe E.E., Traaseth N.J., and Veglia G. Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban. Biochemistry 44 (2005) 4386-4396
24. Veglia G., Zeri A.C., Ma C., and Opella S.J. Deuterium/hydrogen exchange factors measured by solution nuclear magnetic resonance spectroscopy as indicators of the structure and topology of membrane proteins. Biophys. J. 82 (2002) 2176-2183
25. 2+-ATPase with tightly bound fluoride and magnesium against detergent induced denaturation. J. Biol. Chem. 277 (2002) 13615-13619
26. 2+-ATPase. Biochemistry 17 (1978) 1683-1690
27. 2+-ATPase (SERCA2) and phospholamban. FEBS Letters 273 (1990) 232-234
28. 2+-ATPase. J. Biol. Chem. 270 (1995) 9390-9397
29. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J. Biol. Chem. 272 (1997) 15872-15880
30. 2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum. J. Biol. Chem. 261 (1986) 1794-1800
31. 2+/calmodulin-dependent protein kinase. J. Biol. Chem. 271 (1996) 14964-14970
32. 2+-ATPase and phospholamban in High-Five cells. Protein Expr. Purif. 34 (2004) 56-67
33. Matsuo H., Walters K.J., Teruya K., Tanaka T., Gassner G.T., Lippard S.J., et al. Identification by NMR spectroscopy of residues at contact surfaces in large, slowly exchanging macromolecular complexes. J. Am. Chem. Soc. 121 (1999) 9903-9904
34. Wagner G., Pardi A., and Wuthrich K. Hydrogen bond length and proton NMR chemical shifts in proteins. J. Am. Chem. Soc. 105 (1983) 5948-5949
35. Hellstern S., Pegoraro S., Karim C.B., Lustig A., Thomas D.D., Moroders L., and Engel J. Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes. J. Biol. Chem. 276 (2001) 30845-30852
36. 15N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles. Biophys. J. 87 (2004) 1-10
37. Metcalfe E.E., Traaseth N.J., and Veglia G. Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban. Biochemistry 44 (2005) 4386-4396
38. Oxenoid K., and Chou J.J. The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc. Natl Acad. Sci. USA 102 (2005) 10870-10875
39. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
40. 15N NMR relaxation. Biochemistry 33 (1994) 5984-6003
41. Johnson B.A., and Blevins R.A. NMRView a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
42. Nilges M.C., GM, and Gronenborn A.M. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Letters 229 (1988) 317-324
43. Wuthrich K. NMR of Proteins and Nuclear Acids (1986), Wiley, New York
44. Laskowski R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
45. 2+ ATPase. Proc. Natl Acad. Sci. USA 100 (2003) 467-472
46. Traaseth N.J., et al. J. Mol. Biol. (2006) in the press